Skip to main content

Table 1 Association between MALAT1 and clinicopathological parameters

From: Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis

Clinicopathological parameters Studies (n) Patient s (n) OR (95% CI) P Heterogeneity (I2, P) Model
Age (elderly vs. nonelderly) 33 3127 0.983 (0.848–1.140) 0.823 0.0%, 0.991 Fixed
Gender (female vs. male) 28 2459 0.860 (0.726–1.018) 0.080 12.6%, 0.275 Fixed
Tumor size (large size vs. small size) 19 1811 1.875 (1.257–2.795) 0.002 72.8%, 0.000 Random
Lymph node metastasis (positive vs. negative) 26 2440 2.335 (1.606–3.395) 0.000 72.7%, 0.000 Random
Distant metastasis (presence vs. absence) 16 1514 2.456 (1.407–4.286) 0.002 69.9%, 0.000 Random
Differentiation (poor vs. well, moderate) 21 1980 1.112 (0.916–1.351) 0.284 49.6%, 0.005 Fixed
TNM stage (III + IV vs. I + II) 11 1083 2.034 (1.111–3.724) 0.021 77.7%, 0.000 Random
  1. If I2 > 50%, the results were calculated by random model
  2. OR odds ratio, CI confidence interval